168 related articles for article (PubMed ID: 3028719)
1. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
Araki K; Nagashima H; Tsuji T
Clin Exp Immunol; 1982 Mar; 47(3):520-6. PubMed ID: 6282506
[TBL] [Abstract][Full Text] [Related]
3. [Progressive increase of serum circulating immune complexes and its significance in patients during the progression from chronic hepatitis B to hepatocellular carcinoma].
Du J; Tian P; Chen TY; Wu JX; Wang JB; Wei Y; Wang LM; Liu LG; Ji WS; Qu CF
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):905-10. PubMed ID: 22340099
[TBL] [Abstract][Full Text] [Related]
4. Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Tsai JF; Tsai JH; Chang WY
Gastroenterol Jpn; 1990 Jun; 25(3):388-93. PubMed ID: 1694150
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.
Brown SE; Howard CR; Steward MW; Ajdukiewicz AB; Whittle HC
Clin Exp Immunol; 1984 Feb; 55(2):355-9. PubMed ID: 6199140
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes in HBsAg-positive and HBsAg-negative chronic liver diseases.
Pastore G; Schena FP; Angarano G; Monno L; Santantonio T; Pertosa G; Schiraldi O
Ric Clin Lab; 1984; 14(1):29-35. PubMed ID: 6427879
[TBL] [Abstract][Full Text] [Related]
7. Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Tsai JF; Tsai JH; Chang WY; Ton TC
Cancer Invest; 1991; 9(2):137-43. PubMed ID: 1713804
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes detected by C1q solid phase assay in leprosy.
Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
[TBL] [Abstract][Full Text] [Related]
9. Chronic liver disease: the detection and characterization of circulating immune complexes.
Brown SE; Steward MW; Viola L; Howard CR; Murray-Lyon IM
Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
[TBL] [Abstract][Full Text] [Related]
10. [Circulating immune complexes, detection in human glomerulonephritis by the PEG-EDTA technique (author's transl)].
Laurent B; Gonthier R; Genin C; Toulon J; Laurent P; Sabatier JC; Berthoux FC
Pathol Biol (Paris); 1982 Mar; 30(3):141-6. PubMed ID: 6808442
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
[TBL] [Abstract][Full Text] [Related]
12. [Specificity, sensitivity and reproducibility of 2 methods of determining serum immunocomplexes (solid-phase C1q and polyethylene glycol precipitation)].
Coppo R; De Marchi M; Basolo B; Martina G; Rollino C; Boero R; Giraudo G; Rossano C; Quarello F; Piccoli G
Arch Sci Med (Torino); 1982; 139(4):381-92. PubMed ID: 6984818
[TBL] [Abstract][Full Text] [Related]
13. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
[TBL] [Abstract][Full Text] [Related]
15. Studies on circulating soluble immune complexes of the liver disease. 7. Immune complexes in the clinical course and their ultracentrifugal analysis.
Narumoto J
Gastroenterol Jpn; 1981; 16(2):186-92. PubMed ID: 6262181
[TBL] [Abstract][Full Text] [Related]
16. [Acute viral hepatitis in the Florence area: II. Immunologic study].
Passaleva A; Massai G; Leoncini F; Dionisio D; Paci P; Ricci M
Boll Ist Sieroter Milan; 1983 Jul; 62(3):224-37. PubMed ID: 6639776
[TBL] [Abstract][Full Text] [Related]
17. Correlation between circulating antigens detected by the radioimmunoprecipitation-polyethylene glycol assay (RIPEGA) and C1q-binding immune complexes in human schistosomiasis mansoni.
Santoro F; Prata A; Silva AE; Capron A
Am J Trop Med Hyg; 1981 Sep; 30(5):1020-5. PubMed ID: 6974508
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating immune complexes in patients with squamous cell carcinoma of the oral cavity.
Mukhopadhyaya R; Rao RS; Fakih AR; Gangal SG
J Clin Lab Immunol; 1986 Dec; 21(4):189-93. PubMed ID: 3494132
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complex-like materials which bind to heat inactivated C1q interfere with the C1q solid phase assay for immune complexes.
Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Saito T; Furuyama T; Yoshinaga K
Tohoku J Exp Med; 1985 Aug; 146(4):449-56. PubMed ID: 3907015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]